Cabenuva (Cabotegravir/Rilpivirine)
- Medicine Name: Cabenuva
- Generic Name: Cabotegravir; Rilpivirine
- Dosage Form & Strength: Injection: 200 mg/mL; 300 mg/mL
- Manufactured By: ViiV Healthcare
Medical Uses
Cabenuva contains two drugs Cabotegravir (an HIV-1 integrase strand transfer inhibitor), and Rilpivirine (an HIV-1 non-nucleoside reverse transcriptase inhibitor). It is used as a complete regimen to treat HIV-1 infection in adults and adolescents aged 12 years and older and weighing at least 35 kg to replace the current antiretroviral therapy (ART).
Recommended Dosage: Cabenuva should be administered by a health specialist by gluteal intramuscular injection. Cabenuva injection may be initiated with oral Cabotegravir and Rilpivirine before intramuscular injections or the patient may proceed directly to this injection without an oral lead-in.
Cabenuva dosage can be injected monthly or every two months. Health specialists should discuss these 2 dosing options with the respective patients before initiating Cabenuva therapy and specify which dosing frequency would be the most apt option for the patient.
Recommended Monthly Dosing Schedule: Start treatment with Cabenuva (600 mg of cabotegravir and 900 mg of rilpivirine) on the final day of current ART or oral lead-in and continue with Cabenuva (400 mg of cabotegravir and 600 mg of rilpivirine) every month thereafter.
Recommended Every-2-Month Dosing Schedule: Start treatment with Cabenuva (cabotegravir 600 mg and rilpivirine 900 mg) on the final day of current ART or oral lead-in for two consecutive months and continue with Cabenuva injections every two months thereafter.
Warning & Precautions
- Hypersensitivity reactions may occur with rilpivirine-containing therapies and in association with other existing integrase inhibitors. Discontinue Cabenuva treatment promptly if signs/symptoms of hypersensitivity reactions develop.
- Precisely follow the words for use when preparing and using the medication Cabenuva. Inject suspensions slowly via intramuscular injection. The care must be considered to avoid accidental intravenous administration. Assess patients briefly (around 10 minutes) after the injection. If a post-injection reaction occurs, patients should be evaluated and treated as clinically required.
- Hepatotoxicity may occur in all those receiving cabotegravir or rilpivirine with or without known pre-existing hepatic complications or identifiable risk factors. The evaluation of liver chemistries is required and therapy with Cabenuva needs to be discontinued if hepatotoxicity is suspected.
- Depressive disorders may be reported with this treatment or individual medicine products. Promptly assess those with depressive symptoms to evaluate whether the symptoms are related to this medication and to specify whether the risks of continued therapy outweigh the potential benefits.
- The concomitant administration of Cabenuva and other drugs may cause known or potentially significant drug interactions, some of which may be responsible for side effects, loss of virologic response of Cabenuva, and probable development of viral resistance.
Documentation & Availability
What documents are required to import CABENUVA to India?
CABENUVA (cabotegravir/rilpivirine) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is CABENUVA available in India?
\CABENUVA (cabotegravir/rilpivirine injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
CABENUVA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of CABENUVA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Cabenuva price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the CABENUVA (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Cabenuva®?
Cabotegravir; Rilpivirine is a Generic Name for the trade name drug Cabenuva®.
What is the Manufacturer’s Name of Cabenuva®?
Cabenuva® is manufactured by ViiV Healthcare.
Is Cabenuva® approved by the FDA?
Yes, Cabenuva® is approved by the FDA. Date of first/initial approval: January 21, 2021.
Where can I get Cabenuva® at the best price in India?
To get the best Cabenuva injection price in India, kindly contact S S Healthcare (a WHO GDP & ISO 9001:2008 certified company). For Cabenuva®, a valid medical prescription is required from your treating physician.
What is the dosage and form of Cabenuva® supplied?
Cabenuva® is supplied as Injections: 200 mg/mL; 300 mg/mL for intramuscular administration.
What are the most common side effects of Cabenuva®?
The most common side effects of Cabenuva® are dizziness, injection site reactions, fatigue, headache, musculoskeletal pain, nausea, pyrexia, sleep disorders, and rash.
How much does Cabenuva cost in India?
The cabenuva cost in India is less and can vary. In order to procure this HIV medication authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Cabenuva®?
Store Cabenuva in the refrigerator at temperature 2-8°C (36-46°F) in the original carton until the time of use. It is not advisable to freeze it. Avoid mixing it with any other product or diluent.
Is it safe to buy Cabenuva® online from India?
Yes, you can buy Cabenuva injection from India at the best price from the S S Healthcare if the drug Cabenuva has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Cabenuva®?
Click Here to download full Cabenuva prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
